BET1

Bet1 golgi vesicular membrane trafficking protein O15155 BET1_HUMAN
Protein Coding Chr 7 7q21.3 Swiss-Prot reviewed Entrez 10282
Mutations
86
CL 20 · Tissue 63
Samples
44
CL 12 · Tissue 31
Peptides
47
unique mutant peptides
Transcripts
3
isoforms mutated

Stats by Source

Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)

How the counts split by source
Stats by Source

Total = all mutations for this gene across every source.

Cell line = COSMIC Cell Lines Project + DepMap + PubMed.

Tissue = COSMIC primary-tissue (patient tumour) samples.

Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.

TotalCell lineTissue
Mutations862063
Samples441231
Peptides47837

Function

BET1 · Bet1 golgi vesicular membrane trafficking protein

This gene encodes a golgi-associated membrane protein that participates in vesicular transport from the endoplasmic reticulum (ER) to the Golgi complex. The encoded protein functions as a soluble N-ethylaleimide-sensitive factor attachment protein receptor and may be involved in the docking of ER-derived vesicles with the cis-Golgi membrane. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015].

Isoforms & Proteins

3 transcripts · UniProt mapping is sequence-verified (AA-safe)

About the isoform mapping
Isoforms & Proteins

Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.

The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.

Counts are mutations and unique mutant peptides on each transcript.

TranscriptUniProtMutationsPeptides
ENST00000222547 O15155 38 30
ENST00000425626 C9JTT8* 25 24
ENST00000433727 O15155-2 23 23

Gene Properties

Type
Protein Coding
Chromosome
7
Cytoband
7q21.3
Entrez ID
Aliases
HBET1MDRP

Recurrent Mutations

All 30 amino-acid changes on canonical ENST00000222547 · needle height = samples · drag the mini-map to zoom

What this lollipop shows
Recurrent Mutations

A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).

X-axis = amino-acid position in the protein.

Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.

The most recurrent changes are labelled; hover any needle for the change, position and counts.

Mutation frequency across cancer types

% of samples with a missense/complex mutation in BET1 · cell line vs tissue

How this frequency is counted
Cancer-type mutation frequency

For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in BET1 – counted as distinct samples (a sample counts once no matter how many mutations it has).

Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.

Cancer typeCell linesTissue samples
T-Lymphoblastic Leukemia
2/40 5%
0/0 0%
Unknown
0/10 0%
1/29 3%
Endometrial Carcinoma
0/42 0%
7/612 1%
Melanoma
1/210 0%
9/1899 0%
Plasma Cell Myeloma
0/44 0%
1/305 0%
Non-Small Cell Lung Carcinoma
0/304 0%
4/1390 0%
Biliary Tract Carcinoma
1/54 2%
1/950 0%
Small Cell Lung Carcinoma
0/9 0%
1/752 0%
Other Sarcomas
1/69 1%
0/699 0%
Colorectal Carcinoma
2/143 1%
2/3239 0%
Squamous Cell Lung Carcinoma
0/57 0%
1/810 0%
B-Lymphoblastic Leukemia
3/55 5%
0/2640 0%
Gastric Carcinoma
0/74 0%
2/1809 0%
Hepatocellular Carcinoma
0/46 0%
2/2210 0%
Neuroblastoma
1/87 1%
0/1331 0%
Esophageal Squamous Cell Carcinoma
1/51 2%
0/2550 0%
Breast Carcinoma
0/144 0%
1/3264 0%

Mutation Distribution

Where BET1 is mutated · all tissues, split by cell line vs tissue

Mutation counts by tissue
Mutation Distribution

How many mutations in BET1 were found in each tissue, across the whole database.

Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.

This shows the cancer-context where this gene is recurrently altered.

GTEx Expression

Median TPM across 54 healthy tissues

GTEx Portal ↗
About the expression data
GTEx Expression

Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.

Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.

Scroll or drag the mini-axis below the chart to browse all tissues.

Mutations

All 86 mutations in BET1

About the mutation list
Mutations

Every mutation record for this gene, across all samples and sources.

The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).

Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.

IDSampleTranscriptAA Change CDSTypeSourceMutant PeptideWild-type Peptide